Back to search

Article

Nicotinamide mononucleotide enhances the efficacy and persistence of CD19 CAR-T cells via NAD + –Sirt1 axis

2022-04-19

Abstract excerpt

<title>Abstract</title> <p>Chimeric antigen receptor (CAR)-modified T cells targeting antigens expressed on tumor cells have exhibited significant antitumor effects on several types of hematological malignancies, including acute myeloid leukemia, lymphoma, B cell maturation antigen, and CD19-positive acute lymphoblastic leukemia. However, several drawbacks, particularly the poor persistence, limit the use of CAR-...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
300bcb79-303d-5c44-88d2-f69b4bbf5a2a
DOI
10.21203/rs.3.rs-1483519/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Nicotinamide mononucleotide enhances the efficacy and persistence of CD19 CAR-T cells via NAD + –Sirt1 axisDOI 10.21203/rs.3.rs-1483519/v1
Select a neighboring publication to make it the new centre.